Escherichia coli-asparaginase (Elspar) is superior to Erwinia-asparaginase (Erwinase) in childhood acute lymphoblastic leukaemia (ALL) induction--an early response study using minimal residual disease (MRD) markers.
Kwok
C S N
CS
Division of Paediatric Haematology-Oncology, The Children's Medical Institute National University Hospital, National University of Singapore.
Kham
S K Y
SK
Ariffin
H
H
Lin
H P
HP
Quah
T C
TC
Yeoh
A E J
AE
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001215:Asparaginase / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D016974:Dickeya chrysanthemi / Q000201:enzymology; D004926:Escherichia coli / Q000201:enzymology; D006801:Humans; D007223:Infant; D008214:Lymphocytes / Q000187:drug effects; D018365:Neoplasm, Residual; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D012074:Remission Induction; D018570:Risk Assessment
D000970:Antineoplastic Agents; D001215:Asparaginase